Northwest Bancshares, Inc. Gilead Sciences, Inc. Transaction History

Northwest Bancshares, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$72.34 - $84.0 $3.79 Million - $4.4 Million	-52,425 Closed	0 $0
Q1 2020 May 05, 2020	BUY	$62.63 - $80.22 $173,860 - $222,690	2,776 Added 5.59%	52,425 $3.92 Million
Q4 2019 Feb 10, 2020	BUY	$61.62 - $67.78 $308,161 - $338,967	5,001 Added 11.2%	49,649 $3.23 Million
Q3 2019 Oct 09, 2019	BUY	$62.51 - $69.0 $99,390 - $109,710	1,590 Added 3.69%	44,648 $2.83 Million
Q2 2019 Jul 17, 2019	BUY	$61.87 - $69.38 $111,366 - $124,883	1,800 Added 4.36%	43,058 $2.91 Million
Q1 2019 Apr 24, 2019	BUY	$62.53 - $70.05 $251,433 - $281,671	4,021 Added 10.8%	41,258 $2.68 Million
Q4 2018 Feb 08, 2019	BUY	$60.54 - $79.0 $509,807 - $665,259	8,421 Added 29.22%	37,237 $2.33 Million
Q3 2018 Oct 02, 2018	BUY	$71.28 - $78.92 $167,080 - $184,988	2,344 Added 8.85%	28,816 $2.22 Million
Q2 2018 Aug 09, 2018	BUY	$64.88 - $75.68 $72,535 - $84,610	1,118 Added 4.41%	26,472 $1.88 Million
Q1 2018 May 09, 2018	BUY	$72.84 - $88.8 $123,682 - $150,782	1,698 Added 7.18%	25,354 $1.91 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $1.68 Million - $1.98 Million	23,656	23,656 $1.69 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Northwest Bancshares, Inc., based on Form 13F filings with the SEC.

Stay updated on Northwest Bancshares, Inc. with notifications on news.